53
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Pleural injury and pleurisy‐induced progelatinase B/proMMP‐9 is associated with markers of neutrophil degranulation

, , &
Pages 487-496 | Received 16 Nov 2005, Accepted 20 Apr 2006, Published online: 08 Jul 2009

References

  • Nelson A. R., Fingleton B., Rothenberg M. L., Matrisian L. M. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 2000; 18: 1135–49
  • Dano K., Romer J., Nielsen B. S., Bjorn S., Pyke C., Rygaard J., et al. Cancer invasion and tissue remodeling: cooperation of protease systems and cell types. APMIS 1999; 107: 120–27
  • Kupferman M. E., Fini M. E., Muller W. J., Weber R., Cheng Y., Muschel R. J. Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression. Am J Pathol 2000; 157: 1777–83
  • Itoh T., Tanioka M., Matsuda H., Nishimoto H., Yoshioka T., Suzuki R., et al. Experimental metastasis is suppressed in MMP‐9‐deficient mice. Clin Exp Metastasis 1999; 17: 177–81
  • Collier I. E., Goldberg G. I., Gelatinase B. Handbook of proteolytic enzymes, A. J Barrett, N. D Rawlings, J. F Woessner. Academic Press, San Diego, London, Boston, New York 1998; 1205–10
  • Opdenakker G., Van den Steen P. E., Dubois B., Nelissen I., Van Coillie E., Masure S., et al. Gelatinase B functions as regulator and effector in leukocyte biology. J Leukocyte Biol 2001; 69: 851–9
  • Opdenakker G., Van den Steen P. E., Van Damme J. Gelatinase B. a tuner and amplifier of immune functions. Trends Immunol 2001; 22: 571–9
  • Marshall B. C., Santana A., Xu Q. P., Petersen M. J., Campbell E. J., Hoidal R. J., et al. Metalloproteinases and tissue inhibitors of metalloproteinases in mesothelial cells. Cellular differentiation influences expression. J Clin Invest 1993; 91: 1792–9
  • Eickelberg O., Reichenberger F., Larx R., Tamm M., Habicht J., Wyser C., et al. Quantitative analyses of MMP‐ and TIMP‐isoforms in pleural effusions of different origin. Meeting of the American Thoracic Society 1998, Abstract D23
  • Kotyza J., Havel D., Pešek M., Lošan F. Expression of metalloproteinases MMP‐2 and MMP‐9 in malignant and non‐malignant pleural effusions. Studia Pneumol Phthiseol 2002; 62: 64–70
  • Hurewitz A. N., Zucker S., Manusco P., Wu C. L., Dimassimo B., Lysik R. M., et al. Human pleural effusions are rich in matrix metalloproteinases. Chest 1992; 102: 1808–14
  • Eickelberg O., Sommerfeld C. O., Wyser C., Tamm M., Reichenberger F., Bardin P. G., et al. MMP and TIMP expression pattern in pleural effusions of different origins. Am J Respir Crit Care Med 1997; 156: 1987–92
  • Van den Steen P. E., Dubois B., Nelissen I., Rudd P. M., Dwek R. A., Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase‐9 (MMP‐9). Crit Rev Bioch Molec Biol 2002; 37: 375–36
  • Yan L., Borregaard N., Kjeldsen L., Moses M. A. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase G/MMP‐9 and neutrophil gelatinase‐associated lipocalin (NGAL). J Biol Chem 2001; 276: 37258–65
  • Kjeldsen L., Johnsen A. H., Sengelov H., Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993; 268: 10425–32
  • Kjeldsen L., Cowland J. B., Borregaard N. Human neutrophil gelatinase‐associated lipocalin and homologous proteins in rat and mouse. Biochim Biophys Acta 2000; 1482: 272–83
  • Segura R. M., Alegre J., Varela E., Marti R., Surinach J. M., Jufresa J., et al. Interleukin‐8 and markers of neutrophil degranulation in pleural effusions. Am Respir Crit Care Med 1998; 157: 1565–72
  • Blackwell T. S., Christman J. W. Sepsis and cytokines: current status. Br J Anesthesia 1996; 77: 110–7
  • Chung C. L., Chen Y. C., Chan S. C. Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion. Chest 2003; 123: 1188–95
  • Ross R. T., Burnett C. M. Talc pleurodesis: a new technique. Am Surg 2001; 67: 467–8
  • Sahn S. A. Management of malignant pleural effusions. Monaldi Arch Chest Dis 2001; 56: 394–9
  • Kotyza J., Pešek M., Pužman P., Havel D. Progelatinase B/proMMP‐9 as a marker of pleural inflammation. Exp Lung Res 2004; 30: 297–309
  • Kleiner D. E., Stetler‐Stevenson W. G. Quantitative zymography: Detection of picogram quantities of gelatinases. Anal Bioch 1994; 218: 325–9
  • Van den Steen P. E., Proost P., Grillet B., Brand D. D., Kang A. H., Van Damme J., et al. Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post‐translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J 2002; 19: 379–89
  • Lin C. C., Liu C. C., Lin C. Y. Changes in cell population and tumor necrosis factor, interleukin‐6, and interleukin‐8 in malignant pleural effusions after treatment with intrapleural tetracycline. Am Rev Respir Dis 1993; 147: 1503–6
  • Betsuyaku T., Nishimura M., Takeyabu K., Tanino M., Venge P., Xu S., et al. Neutrophil granule proteins in bronchoalveaolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med 1999; 159: 1985–91
  • Xu S., Venge P. Lipocalins as biochemical markers of disease. Biochim Biophys Acta 2000; 1482: 298–307
  • Faurschou M., Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 2003; 5: 1317–27
  • Larocco M. Inflammation and immunity. C. M Porth. concepts of altered health states, Pathophysiology 1994; 243–51, Lippincott
  • Ro Y., Hamada C., Io H., Hayashi K., Hirahara I., Tomino Y. Rapid, simple, and reliable method for the diagnosis of CAPD peritonitis using the new MMP‐9 test kit. J Clin Lab Anal 2004; 18: 224–30
  • Kotyza J., Pešek M., Bednářová V., Teřl M., Werle B. Pleural fluids associated with metastatic lung tumours are rich in progelatinase B/proMMP‐9. Neoplasma 2005; 52: 338–92

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.